NHS England Healthcare News | 2024 | iPharmaCenter
May 16, 2024 Vyndaqel for Rare Heart Condition Now Available on the NHS Patients on the NHS suffering from a critical heart condition...
top of page
Germany: Preliminary Financial Outcomes Unveiled by Statutory Health Insurance for 2023, reports surplus expenditure of ~€1.9 billion, largely attributed to legislative mandates | iPharmCenter
In their initial financial disclosures, the statutory health insurance providers reveal a surplus expenditure of approximately 1.9...
NICE recommended Keytruda for Hodgkin Lymphoma
Keytruda (pembrolizumab) is suggested as an alternative for managing recurring or stubborn classical Hodgkin lymphoma in individuals aged...
HAS Assessment Outcomes | 2024 | France | Healthcare | Pharma | News | iPharmaCenter
January 08, 2024 ELFABRIO (pegunigalsidase alfa) - Unfavorable Reimbursement Opinion for Fabry Disease The reimbursement outlook for...
Germany healthcare news | 2023 | Bundestag reforms | Digital Health | iPharmaCenter
September 29, 2023 The German government commission urges stable financing for child and adolescent medicine, pediatric outpatient...
NICE Assessment outcomes (3/n) Bimzelx recommended for psoriatic arthritis | iPharmaCenter
November 15, 2023 NICE not recommended Pluvicto for PSMA-positive hormone-relapsed metastatic prostate cancer Lutetium-177 vipivotide...
HAS ASSESSMENT OUTCOMES | FRANCE PHARMA NEWS | médicament nouvelles | 2023 | iPharmaCenter
Find the latest healthcare and pharmaceutical news of France | HAS assessment outcomes and drug approvals in France of 2023
NHS England News | NHS to offer Tagrisso for lung cancer patients
NHS to offer Tagrisso for lung cancer patients NHS England announced that it would roll out Tagrisso (osimertinib) for lung cancer...
bottom of page